| NCT Number | NCT07343245 |
| Lead Sponsor | Daewon Pharmaceutical Co., Ltd. |
| Conditions | Healthy Adult |
| Enrollment | 150 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-02-22 (estimated) |
| Study Completion | 2026-06-17 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-15 |